(Q28368360)

English

Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model (English)

0 references

main subject

Mycobacterium tuberculosis

0 references

1 reference

S P Klemens

1

0 references

M A Grossi

series ordinal

2

0 references

M H Cynamon

series ordinal

3

0 references

language of work or name

English

0 references

publication date

October 1994

0 references

published in

Antimicrobial Agents and Chemotherapy

0 references

volume

38

0 references

issue

10

0 references

page(s)

2245-8

0 references

cites work

Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complex

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284725

retrieved

20 March 2017

Activity of levofloxacin in a murine model of tuberculosis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284725

retrieved

20 March 2017

Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284725

retrieved

20 March 2017

Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284725

retrieved

20 March 2017

In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284725

retrieved

20 March 2017

In vivo activities of new rifamycin derivatives against mycobacteria

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284725

retrieved

20 March 2017

Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284725

retrieved

20 March 2017

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284725

retrieved

2 June 2018

Bactericidal action at low doses of a new rifamycin derivative, 3'-hydroxy-5'-(4-isobutyl-1-piperazinyl) benzoxazinorifamycin (KRM-1648) on Mycobacterium leprae inoculated into footpads of nude mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7840552

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.38.10.2245

0 references

PMC publication ID

284725

0 references

PubMed publication ID

7840552

0 references

ResearchGate publication ID

15357777

0 references

(Q28368360)

Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)